Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.
Abroad (travel likely)Recruiting
Conditions
HIV Infections · Hepatitis B
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Registry Coordinating Center, Wilmington, North Carolina, United States
Study leads
Jessica D Albano, PhD, MPH
Principal Investigator
Syneos Health